These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 17097191

  • 1. Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients.
    Schmittel A, Knödler M, Hortig P, Schulze K, Thiel E, Keilholz U.
    Lung Cancer; 2007 Jan; 55(1):109-13. PubMed ID: 17097191
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer.
    Eisen T, Thatcher N, Leyvraz S, Miller WH, Couture F, Lorigan P, Lüthi F, Small D, Tanovic A, O'Brien M.
    Lung Cancer; 2009 Apr; 64(1):60-5. PubMed ID: 18692272
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
    Onoda S, Masuda N, Seto T, Eguchi K, Takiguchi Y, Isobe H, Okamoto H, Ogura T, Yokoyama A, Seki N, Asaka-Amano Y, Harada M, Tagawa A, Kunikane H, Yokoba M, Uematsu K, Kuriyama T, Kuroiwa Y, Watanabe K, Thoracic Oncology Research Group Study 0301.
    J Clin Oncol; 2006 Dec 01; 24(34):5448-53. PubMed ID: 17135647
    [Abstract] [Full Text] [Related]

  • 4. Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.
    Eckardt JR, von Pawel J, Pujol JL, Papai Z, Quoix E, Ardizzoni A, Poulin R, Preston AJ, Dane G, Ross G.
    J Clin Oncol; 2007 May 20; 25(15):2086-92. PubMed ID: 17513814
    [Abstract] [Full Text] [Related]

  • 5. Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
    Eichbaum MH, Schuetz F, Khbeis T, Lauschner I, Foerster F, Sohn C, Schneeweiss A.
    Anticancer Drugs; 2007 Sep 20; 18(8):963-8. PubMed ID: 17667603
    [Abstract] [Full Text] [Related]

  • 6. A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer.
    Shah C, Ready N, Perry M, Kirshner J, Gajra A, Neuman N, Garziano S.
    Lung Cancer; 2007 Jul 20; 57(1):84-8. PubMed ID: 17399850
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bendamustine hydrochloride in patients with refractory soft tissue sarcoma: a noncomparative multicenter phase 2 study of the German sarcoma group (AIO-001).
    Hartmann JT, Mayer F, Schleicher J, Horger M, Huober J, Meisinger I, Pintoffl J, Käfer G, Kanz L, Grünwald V, German sarcoma group.
    Cancer; 2007 Aug 15; 110(4):861-6. PubMed ID: 17599772
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.
    Friedberg JW, Cohen P, Chen L, Robinson KS, Forero-Torres A, La Casce AS, Fayad LE, Bessudo A, Camacho ES, Williams ME, van der Jagt RH, Oliver JW, Cheson BD.
    J Clin Oncol; 2008 Jan 10; 26(2):204-10. PubMed ID: 18182663
    [Abstract] [Full Text] [Related]

  • 13. A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer.
    Grønberg BH, Bremnes RM, Aasebø U, Brunsvig P, Fløtten O, Amundsen T, von Plessen C, Wang M, Sundstrøm S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2009 Jan 10; 63(1):88-93. PubMed ID: 18538889
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004).
    Miller AA, Herndon JE, Gu L, Green MR, Cancer and Leukemia Group B.
    Lung Cancer; 2005 Jun 10; 48(3):399-407. PubMed ID: 15893009
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.
    Peschel C, Hartmann JT, Schmittel A, Bokemeyer C, Schneller F, Keilholz U, Buchheidt D, Millan S, Izquierdo MA, Hofheinz RD.
    Lung Cancer; 2008 Jun 10; 60(3):374-80. PubMed ID: 18054408
    [Abstract] [Full Text] [Related]

  • 18. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
    Loibl S, Murmann C, Schwedler K, Warm M, Müller L, Heinrich G, Nekljudova V, von Minckwitz G.
    Cancer Chemother Pharmacol; 2009 Apr 10; 63(5):953-8. PubMed ID: 18716777
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.
    Jacot W, Pujol JL, Chakra M, Molinier O, Bozonnat MC, Gervais R, Quantin X.
    Lung Cancer; 2012 Feb 10; 75(2):213-6. PubMed ID: 21831476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.